Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
BOTHELL, WA, Feb. 28, 2020 (GLOBE NEWSWIRE) — COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the “Company”), a clinical stage biotechnology […]